Author:
Bolt Hermann M.,Selinski Silvia,Dannappel Doris,Blaszkewicz Meinolf,Golka Klaus
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference25 articles.
1. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH et al. (1993) Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele in African?Americans. Carcinogenesis 14:1689?1692
2. Braz Vieira de Silva Pontes Z, Vincent-Viry M, Gueguen R, Gatteau MM, Siest G (1992) Acetylation phenotypes and biological variation in a French Caucasian population. Eur J Clin Biochem 31:59?67
3. Butcher NJ, Boukouvala S, Sim E, Minchin RF (2002) Pharmacogenetics of arylamine N-acetyltransferases. Pharmacogenomics J 2:30?42
4. Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB et al. (1992) Determination of CYP1A1 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116?127
5. Cascorbi I, Brockmöller J, Bauer S, Reum T, Roots I (1996) NAT2*12A (803A?G) codes for rapid arylamine N-acetylation in humans. Pharmacogenetics 6:257?259
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献